Aptose Biosciences Inc (APS)

0.78
-0.02(-2.50%)
  • Volume:
    4,893
  • Bid/Ask:
    0.77/0.79
  • Day's Range:
    0.78 - 0.82

APS Overview

Prev. Close
0.8
Day's Range
0.78-0.82
Revenue
-
Open
0.82
52 wk Range
0.75-3.53
EPS
-0.636
Volume
4,893
Market Cap
71.99M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
13,153
P/E Ratio
-0.92
Beta
1.39
1-Year Change
-73.38%
Shares Outstanding
92,294,734
Next Earnings Date
Nov 08, 2022
What is your sentiment on Aptose Biosciences?
or
Market is currently closed. Voting is open during market hours.

Aptose Biosciences Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Aptose Biosciences Inc Analysis

Aptose Biosciences Inc Company Profile

Aptose Biosciences Inc Company Profile

Employees
0
Market
Canada
  • Type:Equity
  • Market:Canada
  • ISIN:CA03835T2002
  • CUSIP:03835T200

Aptose Biosciences Inc. is a Canada-based clinical stage precision oncology biotechnology company. It is engaged in advancing kinase inhibitors to treat unmet medical needs in life-threatening cancers, such as acute myeloid leukemia (AML), certain B-cell malignancies, high-risk myelodysplastic syndrome (MDS) and other hematologic malignancies. Its HM43239 is being evaluated in an international Phase I/II study in patients with relapsed or refractory AML. Its Luxeptinib is being evaluated in a Phase I a/b trial in patients with relapsed or refractory B cell malignancies, and in a separate Phase I a/b trial in patients with relapsed or refractory AML or high-risk MDS. Its APTO-253 is a small molecule MYC oncogene inhibitor at the Phase Ia/b clinical trial stage of development for the treatment of patients with relapsed or refractory (R/R) blood cancers, including AML and high-risk MDS. Its APL-581 is a dual bromodomain and extra-terminal domain motif protein and kinase inhibitor program.

Read More

Analyst Price Target

Average7.80 (+900.54% Upside)
High7.8042
Low7.8042
Price0.78
No. of Analysts1
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • And way down she goes 🎶
    0
    • jk new is already out drops down to 5 from here till next update lol
      0
      • to the moon
        0
        • 10.5 milli shares need to get gobbled up @5.25 first! I think is the reason of drop
          0
          • Is it reaaly a good buy¿ i see alot of buys
            0
            • sell will be below $5.15
              2
              • You were saying...?
                0
            • arql buyout
              0
              • arql buyout
                0
                • What happen to this stock today? I don't see any news for it. Insider trading?
                  0